Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Syncom Formulations (India) LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524470 NSE Symbol: SYNCOMF P/E (TTM) :51.11
ISIN Demat:INE312C01025 Div & Yield %:0 EPS (TTM) :0.27
Book Value (RS) :2.8693234 Market Cap (Rs Cr.):1297.2 Face Value (RS) :1
    Change Company 
YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.290.290.190.040.08
Long Term Debt-Equity Ratio0.000.000.000.000.00
Current Ratio1.091.511.992.321.83
Fixed Assets1.511.511.731.511.43
Inventory11.1510.4412.6713.8015.09
Debtors3.153.094.144.854.73
Interest Cover Ratio8.8114.5685.7929.3451.72
PBIDTM (%)15.3614.5918.4710.699.06
PBITM (%)13.3412.7916.838.716.92
PBDTM (%)13.8513.7118.2810.398.93
CPM (%)10.9610.8113.568.918.08
APATM (%)8.939.0111.926.935.94
ROCE (%)9.5710.4920.4212.189.25
RONW (%)8.399.6617.5110.248.71

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)